Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126793941 | 12679394 | 1 | I | 20160721 | 0 | 20160823 | 20160823 | DIR | 65.00 | YR | M | N | 0.00000 | 20160726 | N | PH | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126793941 | 12679394 | 1 | PS | INDOMETHACIN. | INDOMETHACIN | 1 | Oral | Y | N | 0 | QD | ||||||||
| 126793941 | 12679394 | 2 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 126793941 | 12679394 | 3 | C | ACYCLOVIR. | ACYCLOVIR | 1 | 0 | ||||||||||||
| 126793941 | 12679394 | 4 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 126793941 | 12679394 | 5 | C | AZATHIOPRINE. | AZATHIOPRINE | 1 | 0 | ||||||||||||
| 126793941 | 12679394 | 6 | C | CARVEDILOL. | CARVEDILOL | 1 | 0 | ||||||||||||
| 126793941 | 12679394 | 7 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | 0 | ||||||||||||
| 126793941 | 12679394 | 8 | C | DOCUSATE | DOCUSATE | 1 | 0 | ||||||||||||
| 126793941 | 12679394 | 9 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126793941 | 12679394 | 10 | C | INSULIN ASPART | INSULIN ASPART | 1 | 0 | ||||||||||||
| 126793941 | 12679394 | 11 | C | LAMIVUDINE. | LAMIVUDINE | 1 | 0 | ||||||||||||
| 126793941 | 12679394 | 12 | C | MULTIVITAMIN | VITAMINS | 1 | 0 | ||||||||||||
| 126793941 | 12679394 | 13 | C | NIFEDIPINE. | NIFEDIPINE | 1 | 0 | ||||||||||||
| 126793941 | 12679394 | 14 | C | NYSTATIN ORAL LIQUID | NYSTATIN | 1 | 0 | ||||||||||||
| 126793941 | 12679394 | 15 | C | OXYCODONE | OXYCODONE | 1 | 0 | ||||||||||||
| 126793941 | 12679394 | 16 | C | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
| 126793941 | 12679394 | 17 | C | RANITIDINE. | RANITIDINE | 1 | 0 | ||||||||||||
| 126793941 | 12679394 | 18 | C | SULFAMETHOXAZOLE/TRIMETHOPRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | 0 | ||||||||||||
| 126793941 | 12679394 | 19 | C | TACROLIMUS. | TACROLIMUS | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126793941 | 12679394 | 1 | Gout |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126793941 | 12679394 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126793941 | 12679394 | Acute kidney injury | |
| 126793941 | 12679394 | Drug interaction | |
| 126793941 | 12679394 | Nephropathy toxic |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 126793941 | 12679394 | HP |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126793941 | 12679394 | 1 | 20160716 | 20160721 | 0 |